These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 29688144)
1. Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study. Ahn GY; Kim D; Won S; Song ST; Jeong HJ; Sohn IW; Lee S; Joo YB; Bae SC Lupus; 2018 Jul; 27(8):1338-1347. PubMed ID: 29688144 [TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Borowoy AM; Pope JE; Silverman E; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman D; Urowitz M; Zummer M; Hudson M; Tucker L; Peschken C Semin Arthritis Rheum; 2012 Oct; 42(2):179-85. PubMed ID: 22595642 [TBL] [Abstract][Full Text] [Related]
3. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus. Magro-Checa C; Schaarenburg RA; Beaart HJ; Huizinga TW; Steup-Beekman GM; Trouw LA Lupus; 2016 Jul; 25(8):878-88. PubMed ID: 27252265 [TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108 [TBL] [Abstract][Full Text] [Related]
5. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus. Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359 [TBL] [Abstract][Full Text] [Related]
6. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India. Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787 [TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India. Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097 [TBL] [Abstract][Full Text] [Related]
8. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Jönsen A; Bengtsson AA; Nived O; Ryberg B; Sturfelt G Rheumatology (Oxford); 2002 Nov; 41(11):1308-12. PubMed ID: 12422005 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus. Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102 [TBL] [Abstract][Full Text] [Related]